Cidara Therapeutics, Inc.
Methods for preventing and treating pneumocystis infections
Last updated:
Abstract:
The disclosure relates to methods of prophylactic and therapeutic treatments of a Pneumocystis infection (i.e., an infection caused by Pneumocystis jirovecii) in a subject by administering to the subject a compound of any of formulas (I)-(III) (e.g., a salt of Compound 1, or a neutral form thereof). The disclosure also relates to methods of inhibiting the replication of a Pneumocystis spp. The methods of the disclosure can be useful in immunocompromised subjects.
Status:
Grant
Type:
Utility
Filling date:
1 Aug 2019
Issue date:
22 Sep 2020